WINKLER; Jeffrey

Patent Applications and Registrations

Patent applications and USPTO patent grants for WINKLER; Jeffrey.The latest application filed is for "bisaminoquinolines and bisaminoacridines compounds and methods of their use".

Company Profile

2.8.14

WINKLER; Jeffrey - Wynnewood PA
Winkler; Jeffrey - I Wynnewood PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bisaminoquinolines And Bisaminoacridines Compounds And Methods Of Their Use App 20220241267 - WINKLER; Jeffrey ; et al.	2022-08-04
Compounds, compositions and methods for prevention and/or treatment of cancer Grant 11,369,618 - Ridky , et al. June 28, 2	2022-06-28
Compositions And Methods For Inhibiting Acss2 App 20220117958 - Berger; Shelley L. ; et al.	2022-04-21
Asymmetric bisaminoquinolines and bisaminoquinolines with varied linkers as autophagy inhibitors for cancer and other therapy Grant 11,001,558 - Amaravadi , et al. May 11, 2	2021-05-11
Compounds, Compositions And Methods For Prevention And/or Treatment Of Cancer App 20200306261 - RIDKY; Todd ; et al.	2020-10-01
Dimeric quinacrine derivatives as autophagy inhibitors for cancer therapy Grant 10,774,047 - Amaravadi , et al. Sept	2020-09-15
Novel Bisaminoquinoline Compounds, Pharmaceutical Compositions Prepared Therefrom And Their Use App 20200071272 - Amaravadi; Ravi K. ; et al.	2020-03-05
Asymmetric Bisaminoquinolines And Bisaminoquinolines With Varied Linkers As Autophagy Inhibitors For Cancer And Other Therapy App 20190248747 - Amaravadi; Ravi K. ; et al.	2019-08-15
Asymmetric bisaminoquinolines and bisaminoquinolines with varied linkers as autophagy inhibitors for cancer and other therapy Grant 10,221,140 - Amaravadi , et al.	2019-03-05
Compositions And Methods For Increasing, Or Preventing Or Reversing Loss Of, Skin Pigmentation In A Mammalian Subject App 20180273482 - RIDKY; Todd ; et al.	2018-09-27
Bifunctional AKR1C3 inhibitors/androgen receptor modulators and methods of use thereof Grant 10,071,953 - Penning , et al. September 11, 2	2018-09-11
Bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use Grant 10,047,052 - Amaravadi , et al. August 14, 2	2018-08-14
Asymmetric Bisaminoquinolines And Bisaminoquinolines With Varied Linkers As Autophagy Inhibitors For Cancer And Other Therapy App 20170275252 - Amaravadi; Ravi K ; et al.	2017-09-28
Novel Bisaminoquinoline Compounds, Pharmaceutical Compositions Prepared Therefrom And Their Use App 20170166530 - Amaravadi; Ravi K. ; et al.	2017-06-15
Therapeutic agents Grant 9,540,336 - Rubin , et al. January 10, 2	2017-01-10
Novel Bisaminoquinoline Compounds, Pharmaceutical Compositions Prepared Therefrom And Their Use App 20160168099 - Amaravadi; Ravi K. ; et al.	2016-06-16
Bifunctional AKR1C3 Inhibitors/Androgen Receptor Modulators and Methods of Use Thereof App 20160159731 - Penning; Trevor M. ; et al.	2016-06-09
Bifunctional AKR1C3 inhibitors/androgen receptor modulators and methods of use thereof Grant 9,271,961 - Penning , et al. March 1, 2	2016-03-01
Novel Therapeutic Agents App 20140371228 - Rubin; Harvey ; et al.	2014-12-18
Bifunctional AKR1C3 Inhibitors/Androgen Receptor Modulators and Methods of Use Thereof App 20140107085 - Penning; Trevor M. ; et al.	2014-04-17
Novel Bisaminoquinoline Compounds, Pharmaceutical Compositions Prepared Therefrom And Their Use App 20140050696 - Amaravadi; Ravi K. ; et al.	2014-02-20

Company Registrations

SEC

0001527177

Winkler Jeffrey

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.